Twist Bioscience (TWST) Other Accumulated Expenses (2018 - 2026)

Twist Bioscience (TWST) has reported Other Accumulated Expenses for 9 consecutive years, with $67.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 841.68% year-over-year to $67.8 million; the TTM figure through Mar 2026 stood at $67.8 million (up 841.68% YoY), while the FY2025 annual figure was $35.2 million, up 505.16% from the prior year.
• Other Accumulated Expenses rose to $67.8 million in Q1 2026 per TWST's latest filing, from $13.5 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $67.8 million in Q1 2026 and bottomed at $5.2 million in Q4 2024.
• Historically, Other Accumulated Expenses has averaged $15.5 million across 5 years, with a median of $10.0 million in 2023.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses slumped 60.47% — and 2026, when it surged 841.68%.
• Twist Bioscience's Other Accumulated Expenses stood at $15.8 million in 2022, then plunged by 59.44% to $6.4 million in 2023, then dropped by 18.32% to $5.2 million in 2024, then jumped by 156.89% to $13.5 million in 2025, then jumped by 403.85% to $67.8 million in 2026.
• Business Quant data shows TWST's Other Accumulated Expenses at $67.8 million in Q1 2026, $13.5 million in Q4 2025, and $35.2 million in Q3 2025.